These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24964994)

  • 1. Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndrome.
    Marquis P; Lasch KE; Delgado-Herrera L; Kothari S; Lembo A; Lademacher C; Spears G; Nishida A; Tesler WL; Piault E; Rosa K; Zeiher B
    Clin Transl Gastroenterol; 2014 Jun; 5(6):e59. PubMed ID: 24964994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population.
    Delgado-Herrera L; Lasch K; Zeiher B; Lembo AJ; Drossman DA; Banderas B; Rosa K; Lademacher C; Arbuckle R
    Therap Adv Gastroenterol; 2017 Sep; 10(9):673-687. PubMed ID: 28932269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric assessment of the IBS-D Daily Symptom Diary and Symptom Event Log.
    Rosa K; Delgado-Herrera L; Zeiher B; Banderas B; Arbuckle R; Spears G; Hudgens S
    Qual Life Res; 2016 Dec; 25(12):3197-3208. PubMed ID: 27342236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study.
    McLeod L; Ervin C; Fehnel SE; Eremenco S; Carson RT; Hanlon J; Coons SJ;
    Value Health; 2024 May; 27(5):614-622. PubMed ID: 38311181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial.
    Leighton MP; Lam C; Mehta S; Spiller RC
    Trials; 2013 Jan; 14():10. PubMed ID: 23302220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diarrhea-predominant irritable bowel syndrome: creation of an electronic version of a patient-reported outcome instrument by conversion from a pen-and-paper version and evaluation of their equivalence.
    Delgado-Herrera L; Banderas B; Ojo O; Kothari R; Zeiher B
    Patient Relat Outcome Meas; 2017; 8():83-95. PubMed ID: 28790875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.
    Palsson OS; Baggish JS; Turner MJ; Whitehead WE
    Am J Gastroenterol; 2012 Feb; 107(2):286-95. PubMed ID: 22068664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of an amino acid beverage formulation in diarrhea-predominant irritable bowel syndrome: A pragmatic real-world study.
    Niles SE; Blazy P; Cheuvront SN; Kenefick RW; Vidyasagar S; Smith AB; Fawkes N; Denman W
    World J Gastrointest Pharmacol Ther; 2023 Dec; 14(5):39-49. PubMed ID: 38174291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.
    Heitkemper M; Cain KC; Shulman R; Burr R; Poppe A; Jarrett M
    Dig Dis Sci; 2011 Jul; 56(7):2050-8. PubMed ID: 21290181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an electronic daily uterine fibroid symptom diary.
    Deal LS; Williams VS; Fehnel SE
    Patient; 2011; 4(1):31-44. PubMed ID: 21766892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.
    Lacy BE; Chang L; Rao SSC; Heimanson Z; Sayuk GS
    Clin Ther; 2023 Mar; 45(3):198-209. PubMed ID: 36922331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome.
    Khalilian A; Ahmadimoghaddam D; Saki S; Mohammadi Y; Mehrpooya M
    Biopsychosoc Med; 2021 Feb; 15(1):3. PubMed ID: 33536043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diarrhea-predominant irritable bowel syndrome of spleen deficiency and damp excess treated with fire needling therapy with filiform needle and acupoint application therapy: a randomized controlled trial].
    Shi H; Niu Y; Huang Q; Yang ZM; Yang L
    Zhongguo Zhen Jiu; 2021 Sep; 41(9):984-90. PubMed ID: 34491647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.
    Andrae DA; Patrick DL; Drossman DA; Covington PS
    Health Qual Life Outcomes; 2013 Dec; 11():208. PubMed ID: 24330412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Intestinal Gas Questionnaire: development of a new instrument for measuring gas-related symptoms and their impact on daily life.
    Chassany O; Tugaut B; Marrel A; Guyonnet D; Arbuckle R; Duracinsky M; Whorwell PJ; Azpiroz F
    Neurogastroenterol Motil; 2015 Jun; 27(6):885-98. PubMed ID: 25846412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.